JP2007525213A - 新規の脳性ナトリウム利尿ペプチドの変異体及びその利用方法 - Google Patents

新規の脳性ナトリウム利尿ペプチドの変異体及びその利用方法 Download PDF

Info

Publication number
JP2007525213A
JP2007525213A JP2006550367A JP2006550367A JP2007525213A JP 2007525213 A JP2007525213 A JP 2007525213A JP 2006550367 A JP2006550367 A JP 2006550367A JP 2006550367 A JP2006550367 A JP 2006550367A JP 2007525213 A JP2007525213 A JP 2007525213A
Authority
JP
Japan
Prior art keywords
pea
humnatpep
sequence
bnp
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006550367A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007525213A5 (enExample
Inventor
コジョカル，ガッド，エス．
ディベル，アレキサンダー
ノヴィク，アミト
ポロック，サラ
レビン，ズリット
コーエン，ヨッシ
アヤロン−ソファー，マイケル
Original Assignee
コンピュゲン ユーエスエイ，インク．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by コンピュゲン ユーエスエイ，インク． filed Critical コンピュゲン ユーエスエイ，インク．
Priority claimed from PCT/IB2005/000995 external-priority patent/WO2005072055A2/en
Publication of JP2007525213A publication Critical patent/JP2007525213A/ja
Publication of JP2007525213A5 publication Critical patent/JP2007525213A5/ja
Pending legal-status Critical Current

Links

Images

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP2006550367A 2004-01-27 2005-01-27 新規の脳性ナトリウム利尿ペプチドの変異体及びその利用方法 Pending JP2007525213A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US53912704P 2004-01-27 2004-01-27
US62201604P 2004-10-27 2004-10-27
US62232004P 2004-10-27 2004-10-27
US62819004P 2004-11-17 2004-11-17
PCT/IB2005/000995 WO2005072055A2 (en) 2004-01-27 2005-01-27 Novel brain natriuretic peptide variants and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2007525213A true JP2007525213A (ja) 2007-09-06
JP2007525213A5 JP2007525213A5 (enExample) 2008-03-21

Family

ID=38556367

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006550367A Pending JP2007525213A (ja) 2004-01-27 2005-01-27 新規の脳性ナトリウム利尿ペプチドの変異体及びその利用方法

Country Status (1)

Country Link
JP (1) JP2007525213A (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011010732A1 (ja) 2009-07-23 2011-01-27 株式会社 イギス 皮膚外用剤組成物
WO2011024973A1 (ja) 2009-08-27 2011-03-03 株式会社 イギス 鼻炎治療剤
WO2012099258A1 (ja) 2011-01-21 2012-07-26 株式会社 イギス 脱毛症治療剤
EP4014987A2 (en) 2015-05-29 2022-06-22 Igisu Co., Ltd. Cyclic peptide, and medicine, external preparation and cosmetic each containing said cyclic peptide

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999013331A1 (en) * 1997-09-11 1999-03-18 Shionogi & Co., Ltd. Immunoassay method for bnp

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999013331A1 (en) * 1997-09-11 1999-03-18 Shionogi & Co., Ltd. Immunoassay method for bnp

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9358269B2 (en) 2009-07-23 2016-06-07 Igisu Co., Ltd Method for treating dermatitis and improving skin texture using natriuretic peptides
US10946072B2 (en) 2009-07-23 2021-03-16 Igisu Co., Ltd. Method for treating dermatitis and improving skin texture using B-type natriuretic peptides
US9968654B2 (en) 2009-07-23 2018-05-15 Igisu Co., Ltd. Method of treatment dermatitis with c-type natriuretic peptide derivatives
WO2011010732A1 (ja) 2009-07-23 2011-01-27 株式会社 イギス 皮膚外用剤組成物
US9358270B2 (en) 2009-08-27 2016-06-07 Igisu Co., Ltd. Method of treating rhinitis with B-type and C-type natriuretic peptides
US9962429B2 (en) 2009-08-27 2018-05-08 Igisu Co., Ltd. Method for treating rhinitis with B and C-type natriuretic peptide containing chimeric ring structures
WO2011024973A1 (ja) 2009-08-27 2011-03-03 株式会社 イギス 鼻炎治療剤
US11452762B2 (en) 2009-08-27 2022-09-27 Igisu Co., Ltd. Method of treating rhinitis with C-type natriuretic peptides
US9480728B2 (en) 2011-01-21 2016-11-01 Igisu Co., Ltd. Agent for the treatment of alopecia
US9808511B2 (en) 2011-01-21 2017-11-07 Igisu Co., Ltd. Method for treating alopecia with B-type natriuretic peptide
WO2012099258A1 (ja) 2011-01-21 2012-07-26 株式会社 イギス 脱毛症治療剤
US11571464B2 (en) 2011-01-21 2023-02-07 Igisu Co., Ltd. C-type natriuretic peptide agent for the treatment of alopecia
EP4014987A2 (en) 2015-05-29 2022-06-22 Igisu Co., Ltd. Cyclic peptide, and medicine, external preparation and cosmetic each containing said cyclic peptide
US12065512B2 (en) 2015-05-29 2024-08-20 Igisu Co., Ltd. Cyclic peptide and a medicament, external preparation and cosmetic comprising said cyclic peptide
US12221495B2 (en) 2015-05-29 2025-02-11 Igisu Co., Ltd. Cyclic peptide and a medicament, external preparation and cosmetic comprising said cyclic peptide

Similar Documents

Publication Publication Date Title
EP1730181A2 (en) Novel brain natriuretic peptide variants and methods of use thereof
US20080182299A1 (en) Novel brain natriuretic peptide variants and methods of use thereof
US20060147946A1 (en) Novel calcium channel variants and methods of use thereof
WO2006131928A2 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
WO2005084116A2 (en) Calcium channel variants
JP2005536186A (ja) リンパ管および血管内皮細胞遺伝子
JP2010524427A (ja) 慢性移植片機能障害のためのバイオマーカー
WO2004076639A2 (en) Use of gene expression profiling in the diagnosis and treatment of lupus nephritis and systemic lupus erythematosus
US20030124551A1 (en) Agents implicated in endometriosis
Owen et al. Identification and characterization of the genes encoding human and mouse osteoactivin
JPH10513045A (ja) ヒトの胎児の脾臓で発現する新規なケモカイン、その産生と使用
AU2008202807A1 (en) Methods and compositions targeting tyrosine kinases for the diagnosis and treatment of osteoarthritis
WO2006090389A2 (en) Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof
US7332569B2 (en) Brain natriuretic peptide spliced variant
EP1690932A1 (en) Bone and/or joint disease-associated gene
CA2527957A1 (en) Use of genes differentially expressed during aging of liver for treatment and diagnosis
JP2003524366A (ja) ６４個のヒト分泌タンパク質
Lalouel et al. Development of genetic hypotheses in essential hypertension
US20060188885A1 (en) High throughput functional genomic screening methods for osteoarthritis
JP2007525213A (ja) 新規の脳性ナトリウム利尿ペプチドの変異体及びその利用方法
JPH10512154A (ja) 膵臓で発現する新規なケモカイン
US20050186600A1 (en) Polynucleotides encoding novel UbcH10 polypeptides and kits and methods using same
JP2008507261A (ja) 肺癌診断のための新規のヌクレオチド配列およびアミノ酸配列、ならびにそのアッセイおよび使用方法
JP2004505637A (ja) ガン関連ｓｉｍ２遺伝子
JPH11504212A (ja) 新規なカテプシンｃホモログ

Legal Events

Date Code Title Description
RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20071129

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080116

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080116

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20100907

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100928

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110401